Efficacy and safety of tenofovir disoproxil fumarate treatment during the second or third trimester of pregnancy for preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis

Wu Xiaoyan1, Gao Xuesong2, Liu Ruyu3, Guo Jiang4, Cai Haodong3

PDF(4950 KB)
PDF(4950 KB)
Adverse Drug Reactions Journal ›› 2020, Vol. 22 ›› Issue (2) : 85-94. DOI: 10.3760/cma.j.issn.1008-5734.2020.02.006

Efficacy and safety of tenofovir disoproxil fumarate treatment during the second or third trimester of pregnancy for preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 22(2): 85-94 https://doi.org/10.3760/cma.j.issn.1008-5734.2020.02.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(4950 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉